Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $759M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HROW | HARROW INC | 2,832,230 | $99.86M | 13.2% | $6.33 | +659.8% | COM | 415858109 |
| LQDA | LIQUIDIA CORPORATION | 2,545,000 | $88.82M | 11.7% | $13.06 | +190.4% | COM NEW | 53635D202 |
| ETON | ETON PHARMACEUTICALS INC | 2,860,000 | $70.58M | 9.3% | $5.71 | +180.0% | COM | 29772L108 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 500,000 | $39.61M | 5.2% | $32.61 | +103.6% | SHS NEW | M8694L137 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 123,000 | $35.32M | 4.7% | $12.73 | +707.7% | COM | 76243J105 |
| APGE | APOGEE THERAPEUTICS INC | 390,000 | $32.83M | 4.3% | $39.78 | +81.6% | COM | 03770N101 |
| IRON | DISC MEDICINE INC | 421,000 | $26.92M | 3.5% | $63.70 | +16.2% | COM | 254604101 |
| URGN | UROGEN PHARMA LTD | 1,430,000 | $25.71M | 3.4% | $21.00 | -0.8% | COM | M96088105 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,312,615 | $24.11M | 3.2% | $12.57 | -12.0% | COM | G2545C104 |
| STOK | STOKE THERAPEUTICS INC | 700,000 | $22.79M | 3.0% | $11.23 | +183.5% | COM | 86150R107 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 4,675,000 | $19.49M | 2.6% | $3.59 | +7.0% | COM NEW | 46489V302 |
| RZLT | REZOLUTE INC | 6,300,000 | $19.21M | 2.5% | $7.31 | -58.1% | COM NEW | 76200L309 |
| MGTX | MEIRAGTX HLDGS PLC | 2,123,259 | $18.39M | 2.4% | $7.74 | -1.7% | COM | G59665102 |
| TGTX | TG THERAPEUTICS INC | 535,000 | $17.77M | 2.3% | $13.67 | +117.0% | COM | 88322Q108 |
| SNWV | SANUWAVE HEALTH INC | 981,267 | $16.97M | 2.2% | $28.49 | -6.4% | COM | 80303D305 |
| EWTX | EDGEWISE THERAPEUTICS INC | 500,000 | $15.75M | 2.1% | $11.02 | +155.6% | COM | 28036F105 |
| ACOG | ALPHA COGNITION INC | 2,561,950 | $14.07M | 1.9% | $6.32 | -10.3% | COM NEW | 02074J501 |
| ANNX | ANNEXON INC | 2,331,761 | $12.92M | 1.7% | $2.48 | +131.5% | COM | 03589W102 |
| ALMS | ALUMIS INC | 550,000 | $12.12M | 1.6% | $5.26 | +362.7% | COM | 022307102 |
| CDXS | CODEXIS INC | 6,785,000 | $11.06M | 1.5% | $2.81 | -49.2% | COM | 192005106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 100,000 | $10.54M | 1.4% | $17.50 | +376.0% | COM | 74366E102 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $9.725M | 1.3% | $38.42 | +168.2% | COM | 76155X100 |
| XOMA | XOMA ROYALTY CORPORATION | 300,000 | $9.411M | 1.2% | $14.38 | +81.7% | COM NEW | 98419J206 |
| QTTB | Q32 BIO INC | 1,256,228 | $8.065M | 1.1% | $3.75 | +5.1% | COM | 746964105 |
| MBX | MBX BIOSCIENCES INC | 260,000 | $7.761M | 1.0% | $11.09 | +232.1% | COM | 55287L101 |
| RLMD | RELMADA THERAPEUTICS INC | 935,000 | $6.508M | 0.9% | $3.35 | +19.8% | COM | 75955J402 |
| CGON | CG ONCOLOGY INC | 94,800 | $6.416M | 0.8% | $27.46 | +90.9% | COM | 156944100 |
| JBIO | JADE BIOSCIENCES INC | 427,608 | $6.008M | 0.8% | $11.73 | +26.0% | COM NEW | 008064206 |
| OCUL | OCULAR THERAPEUTIX INC | 600,000 | $5.082M | 0.7% | $5.10 | +92.9% | COM | 67576A100 |
| ASRT | ASSERTIO HOLDINGS INC | 265,707 | $5.064M | 0.7% | $11.33 | 0.0% | COM NEW | 04546C304 |
| EDIT | EDITAS MEDICINE INC | 1,926,997 | $4.76M | 0.6% | $1.99 | 0.0% | COM | 28106W103 |
| STRO | SUTRO BIOPHARMA INC | 190,671 | $4.75M | 0.6% | $9.49 | +58.9% | COM SHS | 869367201 |
| DERM | JOURNEY MED CORP | 960,000 | $4.502M | 0.6% | $7.08 | +15.9% | COM | 48115J109 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,150,000 | $4.439M | 0.6% | $3.93 | — | COM | 92915B106 |
| TRVI | TREVI THERAPEUTICS INC | 345,100 | $4.117M | 0.5% | $2.06 | +431.9% | COM | 89532M101 |
| TECX | TECTONIC THERAPEUTIC INC | 123,000 | $3.802M | 0.5% | $18.58 | +13.5% | COM | 878972108 |
| CABA | CABALETTA BIO INC | 1,380,000 | $3.712M | 0.5% | $2.08 | +25.9% | COM | 12674W109 |
| BDSX | BIODESIX INC | 238,047 | $3.452M | 0.5% | $9.93 | 0.0% | COM | 09075X207 |
| RCKT | ROCKET PHARMACEUTICALS INC | 955,000 | $3.419M | 0.5% | $3.42 | +5.5% | COM | 77313F106 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 1,412,656 | $3.306M | 0.4% | $1.88 | +39.2% | COM | 98943L107 |
| NTLA | INTELLIA THERAPEUTICS INC | 245,000 | $3.141M | 0.4% | $12.40 | 0.0% | COM | 45826J105 |
| FBIO | FORTRESS BIOTECH INC | 1,042,000 | $2.907M | 0.4% | $2.85 | +25.6% | COM NEW | 34960Q307 |
| IRD | OPUS GENETICS INC | 1,120,000 | $2.251M | 0.3% | $1.13 | +143.4% | COM | 67577R102 |
| RIGL | RIGEL PHARMACEUTICALS INC | 70,000 | $1.893M | 0.2% | $33.50 | +10.6% | COM | 766559702 |
| AVIR | ATEA PHARMACEUTICALS INC | 322,600 | $1.736M | 0.2% | $3.53 | +12.7% | COM | 04683R106 |
| LYEL | LYELL IMMUNOPHARMA INC | 79,097 | $1.587M | 0.2% | $24.33 | 0.0% | COM NEW | 55083R203 |
| ENTA | ENANTA PHARMACEUTICALS INC | 125,000 | $1.579M | 0.2% | $13.02 | +3.6% | COM | 29251M106 |
| NXTC | NEXTCURE INC | 141,181 | $1.508M | 0.2% | $12.58 | 0.0% | COM NEW | 65343E207 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 112,291 | $1.045M | 0.1% | $8.57 | 0.0% | COM | 35104E100 |
| — | PERSPECTIVE THERAPEUTICS INC | 200,000 | $834K | 0.1% | $4.17 | — | CALL | 46489V902 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | 340,000 | $738K | 0.1% | $1.63 | +50.3% | COM | 74365A309 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 53,282 | $477K | 0.1% | $8.95 | — | COM NEW | 107924102 |
| LBRX | LB PHARMACEUTICALS INC | 14,506 | $358K | 0.0% | $22.38 | 0.0% | COM SHS | 50180M108 |
| ADGM | ADAGIO MED HLDGS INC | 18,444 | $21,211 | 0.0% | $4.76 | -79.4% | COM | 00534B100 |